Shimla Online

Renal Cell Carcinoma Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

Renal Cell Carcinoma Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

DelveInsight’s, “Renal Cell Carcinoma Pipeline Insight, 2023,” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in the Renal Cell Carcinoma pipeline landscape. It covers the Renal Cell

Read Full Article

STEMart Introduces Bioburden Tissue Testing Services for Medical Devices

STEMart has recently introduced Bioburden Tissue Testing services for medical applications, including Aerobic Count, Anaerobic Count, Fungi/Mold Count, and Spore Count. New York, USA – January 23, 2023 – STEMart,

Read Full Article

Refractory Multiple Myeloma Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

DelveInsight’s ‘Refractory Multiple Myeloma Pipeline Insight 2022’ report provides comprehensive global coverage of available, marketed, and pipeline refractory multiple myeloma therapies in various stages of clinical development, major pharmaceutical companies

Read Full Article

CD BioSciences Introduces New Solutions to Support Cell Death Studies

CD BioSciences recently launched a comprehensive panel of research solutions covering all aspects of cell death studies. New York, USA – January 23, 2023 – CD BioSciences, a US-based CRO

Read Full Article

Prostate Cancer Pipeline Appears Robust With 200+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

DelveInsight’s, “Prostate Cancer Pipeline Insight, 2022,” report provides comprehensive insights about 200+ companies and 200+ pipeline drugs in Prostate Cancer

Read Full Article

CD BioSciences Launches Scaffold-Based Technologies for 3D Cell Culture

CD BioSciences has recently announced the launch of scaffold-based technologies to assist researchers in achieving organotypic co-culture and simulating layered

Read Full Article

Pancreatic Ductal Adenocarcinoma Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

DelveInsight’s, “Pancreatic Ductal Adenocarcinoma Pipeline Insight, 2022,” report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the

Read Full Article

Mr. Erik Solheim joins Advisory Board of Updapt (an ESG Tech Co.)

Updapt, a SaaS based ESG Solution Co., announced today that Mr. Erik Solheim, a Green Leader and Norwegian Diplomat, has

Read Full Article

Pancreatic Cancer Pipeline Appears Robust With 120+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

DelveInsight’s, “Pancreatic Cancer Pipeline Insight, 2023,” report provides comprehensive insights about 120+ companies and 150+ pipeline drugs in Pancreatic Cancer

Read Full Article

Ovarian Cancer Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

DelveInsight’s, “Ovarian Cancer Pipeline Insight, 2022,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Ovarian

Read Full Article